Erik T Dustrude

Title: Innovations by Erik T Dustrude in Chronic Pain Management

Introduction

Erik T Dustrude is an innovative inventor based in Tucson, AZ. He has made significant contributions to the field of chronic pain management through his research and patent work. His dedication to improving the quality of life for individuals suffering from chronic pain is evident in his groundbreaking inventions.

Latest Patents

Erik T Dustrude holds a patent for "Non-narcotic CRMP2 peptides targeting sodium channels for chronic pain." This patent discloses isolated polypeptides capable of preventing collapsin response mediator protein 2 (CRMP2)-small ubiquitin-like modifier (SUMO)ylation mediated trafficking of voltage-gated sodium channel 1.7 (Nav1.7) function. The disclosed peptides comprise three to twenty amino acids and include the amino acid sequence KMD. Additionally, the patent outlines methods of decreasing nociception by administering an effective amount of one or more disclosed peptides to a subject in need, such as those experiencing chronic pain.

Career Highlights

Erik T Dustrude is affiliated with the University of Arizona, where he continues to advance his research in pain management. His work has garnered attention for its potential to provide non-narcotic solutions to chronic pain, a significant issue in modern medicine.

Collaborations

Erik collaborates with esteemed colleagues, including Rajesh Khanna and May Khanna. Their combined expertise enhances the research and development of innovative solutions in the field of pain management.

Conclusion

Erik T Dustrude's contributions to chronic pain management through his innovative patent work exemplify the potential for scientific advancements to improve patient care. His dedication to finding non-narcotic solutions is paving the way for future research in this critical area.